Sign In
Free Newsletter
Catalent moves headquarters from NJ
Following the sale of its Somerset facility, the pharmaceutical company relocated its base to Tampa but retains a corporate office in New Jersey.
Catalent to sell Somerset HQ (updated)
The site also serves as an oral solids development and small-scale manufacturing facility for the pharmaceutical company, which is in talks with Novo Holdings for a $16.5 billion acquisition.
Layoffs hit Kenvue, Catalent
The former is Johnson & Johnson's consumer goods spinoff, while the latter is set to be acquired by Novo Holdings in a recently announced $16.5 million deal.
Novo Holdings to acquire Catalent in $16.5B deal (updated)
The move follows several months of efforts by the Somerset-based pharmaceutical company to “right-size” its business, after struggling with productivity issues and higher-than-expected costs at three of its facilities.
Catalent working to ‘right-size’ company
The Somerset-based pharmaceutical business has added four independent directors, launched a review committee and entered into a cooperation agreement with one of its largest investors.
Catalent brings on new CFO amid headwinds
Succeeding Thomas Castellano, Matti Masanovich has been appointed senior vice president and chief financial officer of the Somerset-based pharmaceutical company, effective July 5.
Ferraro to oversee Catalent’s legal, compliance operations
Joseph Ferraro was appointed senior vice president, general counsel, chief compliance officer and secretary for the Somerset-based company.
Catalent acquires Metrics Contract Services for $475M
The target, Metrics Contract Services, is a division of Mayne Pharma Group Ltd. and operates from a manufacturing facility in Greenville, N.C.
With new CEO in place, Catalent updates operating structure
The Somerset company is streamlining its segments from four to two to help achieve its next level of expansion and achievement, in addition to announcing changes to its leadership team.
Company vet officially takes the helm as Catalent CEO
Alessandro Maselli assumed the role of president and CEO July 1. John Chiminski, meanwhile, transitions to the role of executive chair of the board.
